Form4insider filings, from the source

SEC Form 4/A · accession 0001733439-18-000016

Tracon Pharmaceuticals, Inc. · TCON

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owners
Theodore T Wang
Director · 10% Owner
Period of report
Nov 29, 2018
Accepted (ET)
Dec 3, 2018 · 10:14 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001394319

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF4Nov 29, 2018P4,326$1.13A4,606,094IBy funds
Common StockF4Nov 29, 2018S4,326$1.21D4,601,768IBy funds
Common StockF1holding———4,601,768IBy funds

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Warrants (right to buy)F2,F3$2.70holding———Mar 27, 2018Mar 27, 2024Common Stock4,601,7684,601,768I

Explanation of responses